EARLOBE SARCOIDOSIS

被引:0
|
作者
Vorselaars, A. D. M. [1 ]
Keijsers, R. G. M. [2 ]
Grutters, J. C. [1 ,3 ]
机构
[1] St Antonius Hosp, Ctr Interstitial Lung Dis, Dept Pulmonol, NL-3435 CM Nieuwegein, Netherlands
[2] St Antonius Hosp, Dept Nucl Med, NL-3435 CM Nieuwegein, Netherlands
[3] Univ Med Ctr Utrecht, Div Heart & Lungs, Utrecht, Netherlands
关键词
sarcoidosis; 18F-FDG-PET; Infliximab; TNF-alpha mAb;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Infliximab, a TNF-alpha blocking agent, is an upcoming therapeutic option for cases of refractory sarcoidosis. In pulmonary sarcoidosis, changes imaged by F-18-FDG-PET during infliximab treatment in sarcoidosis patients correlate with signs of clinical improvement. Design: Case-report. Results and conclusions: A patient with severe earlobe sarcoidosis, treated with infliximab, is presented. This case shows that even relatively small extrapulmonary localisations of sarcoidosis can be visualised by F-18-FDG-PET, and that a decrease of FDG-uptake correlates well with clinical improvement on infliximab treatment.
引用
收藏
页码:55 / 57
页数:3
相关论文
共 50 条
  • [21] Diagnosis and Management of Cardiac Sarcoidosis
    Dubrey, Simon W.
    Falk, Rodney H.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2010, 52 (04) : 336 - 346
  • [22] Diagnosis and treatment of hepatic sarcoidosis
    Ayyala U.S.
    Padilla M.L.
    Current Treatment Options in Gastroenterology, 2006, 9 (6) : 475 - 483
  • [23] Fatigue in sarcoidosis: a systematic review
    de Kleijn, Willemien P. E.
    De Vries, Jolanda
    Lower, Elyse E.
    Elfferich, Marjon D. P.
    Baughman, Robert P.
    Drent, Marjolein
    CURRENT OPINION IN PULMONARY MEDICINE, 2009, 15 (05) : 499 - 506
  • [25] Pulmonary Function in Pulmonary Sarcoidosis
    Yao, Qian
    Ji, Qiuliang
    Zhou, Ying
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (21)
  • [26] Biologic therapies in the treatment of sarcoidosis
    Saketkoo, Lesley Ann
    Baughman, Robert P.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (08) : 817 - 825
  • [28] Infliximab for the therapy of chronic sarcoidosis
    Antoniu, Sabina A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (05) : 753 - 756
  • [29] Refractory sarcoidosis responding to infliximab
    Roberts, SD
    Wilkes, DS
    Burgett, RA
    Knox, KS
    CHEST, 2003, 124 (05) : 2028 - 2031
  • [30] Targeting the TNF-α pathway in sarcoidosis
    Antoniu, Sabina A.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (01) : 21 - 29